Details checkedClinical trial listing onlyCheckedregistry

Dexamethasone-Loaded Exosome Intratympanic Delivery Study

Also known as: Exosomes derived from human umbilical cord mesenchymal stem cells, Dexamethasone-loaded exosomes, NCT07568184

Institution-led study

Primary source

Sponsor / Institution

Institution-led study

Program Type

Therapeutic

Modality

Drug Delivery

Stage

Interventional/NA

Status

Active

Target Gene

—

Route / Mode

Intratympanic delivery

Confidence

83%

Status Confidence

Status needs checking

Evidence Strength

Needs more support

Last Reviewed

2026-06-10

Geography

Egypt

Population

adult, sensorineural, sudden

Trial IDs

Mechanism

Institution-led randomized study evaluating intratympanic exosomes, including dexamethasone-loaded exosomes, versus standard therapy in acute sensorineural hearing loss.

Indications

Hearing Loss Sensorineural Hearing Loss Sudden Sensorineural Hearing Loss

Notes

Corrected sponsor from National Research Centre to the registry lead sponsor Kafrelsheikh University while preserving collaborators. The registry phase field is NA even though the official title says Phase II, so HearScape treats this conservatively as an interventional registry-backed academic study rather than a company product.

Evidence & Sources

1 structured sources

clinicaltrials

Supports: canonicalName, aliases, company, allCompanies, isIndustrySponsored, programType, modality, mechanism...

IDs: NCT07568184

Open

Key Events

2026-04-03

Registry lists actual study start for dexamethasone-loaded exosome intratympanic delivery trial

Clinical Trials (1)

NCT07568184

Data Checks